Lisata Therapeutics LSTA
NASDAQ LSTA
$1.02 -0.02 (-1.92%)
As of: Oct 21, 2026 · 2:23 PM EDT

Lisata Therapeutics (LSTA) EBIT Margin (2010 - 2025)

Updated

Lisata Therapeutics' EBIT Margin came in at -2368.46% for Q4 2025, down 1873.56 percentage points from -494.90% a year earlier.

Analysis

Lisata Therapeutics (LSTA) EBIT Margin (2010 - 2025) Analysis & Trends

For FY2025, Lisata Therapeutics' EBIT Margin was -9104.50%, down 6863.60 percentage points from FY2024.

  • Going back by year, EBIT Margin was -2240.90% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,135.59 Bn 1,104.17 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 616.92 Bn 535.45 Bn 17.26 Bn 28.21%
3 AbbVie 501.52 Bn 474.63 Bn 12.70 Bn 37.86%
4 Merck 367.36 Bn 321.74 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.93 Bn 261.92 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 20.57%
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.72 Bn 164.92 Bn 6.22 Bn -133.21%
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn 28.37%
10 Lisata Therapeutics 9.29 Mn -49.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,368.46%
Jun 30, 2025 -6,954.29%
Dec 31, 2024 -494.90%
Mar 31, 2017 -81.19%
Dec 31, 2016 -53.97%
Sep 30, 2016 -61.47%
Jun 30, 2016 -89.22%
Mar 31, 2016 -147.85%
Dec 31, 2015 -789,806.57%
Sep 30, 2015 -176.33%
Jun 30, 2015 -437.52%
Mar 31, 2015 -570.19%
Dec 31, 2014 -294,784.38%
Sep 30, 2014 -394,815.44%
Jun 30, 2014 -276,909.38%
Mar 31, 2014 -332,814.79%
Dec 31, 2013 -257,345.90%
Sep 30, 2013 -251,222.85%
Jun 30, 2013 -187,432.42%
Mar 31, 2013 -349,896.00%
API Access

Lisata Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=LSTA&period=max&api_key=YOUR_API_KEY